Scientists identify over 5,000 genetic variants that enable certain cancers to thrive

FHS
July 10, 2024
9:31 am

Researchers performed saturation genome editing of the BAP1, whose dysfunction is related to cancer and impaired neurodevelopment.

TB cases in England spike by 10.7% in 2023

Figures published today by the UK Health Security Agency (UKHSA) in its TB annual report, show that tuberculosis cases in England in 2022 were stable

February 15, 2024

Parker Institute for Cancer Immunotherapy invests another $125M into research

The Parker Institute for Cancer Immunotherapy, a research network established by tech entrepreneur Sean Parker, announced a new $125 million investment. The latest investment comes

July 19, 2024

DEFENCE’S ACCUM®-mRNA LIPID NANOPARTICLES ELICIT ANTIBODY RESPONSE 2X STRONGER THAN STANDARD mRNA VACCINES – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE’S ACCUM®-mRNA LIPID NANOPARTICLES ELICIT ANTIBODY RESPONSE 2X STRONGER THAN STANDARD mRNA VACCINES 25.09.2023 / 08:00 CET/CEST

September 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.